Association between SNPs in P53 binding regions and risk of esophageal squamous cell carcinoma

International Journal of Biological Markers

Volumn 29, Issue 2, 2014, Pages

  Wang, Kai ^a   Liu, Botao ^a   Li, Juan ^a   Xiong, Gang ^a   Guan, Xingying ^a   Yang, Kang ^a   Bai, Yun ^a  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Association study; Esophageal cancer; P53; SNP

Indexed keywords

PROTEIN P53; TP53 PROTEIN, HUMAN;

ADULT; ALLELE; ARTICLE; CANCER RISK; CANCER STAGING; CANCER SUSCEPTIBILITY; CONTROLLED STUDY; DISEASE ASSOCIATION; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; FEMALE; GENE FREQUENCY; GENETIC VARIABILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; QUESTIONNAIRE; SINGLE NUCLEOTIDE POLYMORPHISM; TUMOR SUPPRESSOR GENE; BINDING SITE; ESOPHAGUS TUMOR; GENETIC PREDISPOSITION; GENETICS; METABOLISM; MIDDLE AGED; SQUAMOUS CELL CARCINOMA;

BINDING SITES; CARCINOMA, SQUAMOUS CELL; ESOPHAGEAL NEOPLASMS; FEMALE; GENES, P53; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84903380697     PISSN: 03936155     EISSN: 17246008     Source Type: Journal    
DOI: 10.5301/jbm.5000061     Document Type: Article

References (30)

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin. 2011; 61(2): 69-90.
2. Wheeler JB, Reed CE. Epidemiology of esophageal cancer. Surg Clin North Am. 2012; 92(5): 1077-1087.
3. Enzinger PC, Mayer RJ. Esophageal cancer. N Engl J Med. 2003; 349(23): 2241-2252.
4. Shu KX, Li B, Wu LX. The p53 network: p53 and its downstream genes. Colloids Surf B Biointerfaces. 2007; 55(1): 10-18.
5. Vogelstein B, Lane D, Levine AJ. Surfing the p53 network. Nature. 2000; 408(6810): 307-310.
6. Harris SL, Levine AJ. The p53 pathway: positive and negative feedback loops. Oncogene. 2005; 24(17): 2899-2908.
7. Ayed A, Mulder FA, Yi GS, Lu Y, Kay LE, Arrowsmith CH. Latent and active p53 are identical in conformation. Nat Struct Biol. 2001; 8(9): 756-760.
8. Speidel D. Transcription-independent p53 apoptosis: an alternative route to death. Trends Cell Biol. 2010; 20(1): 14-24.
9. Zhang M, Zhang P, Zhang C, et al. Prognostic significance of Bcl-2 and Bax protein expression in the patients with oral squamous cell carcinoma. J Oral Pathol Med. 2009; 38(3): 307-313.
10. Cory S, Huang DC, Adams JM. The Bcl-2 family: roles in cell survival and oncogenesis. Oncogene. 2003; 22(53): 8590-8607.
11. el-Deiry WS, Tokino T, Velculescu VE, et al. WAF1, a potential mediator of p53 tumor suppression. Cell. 1993; 75(4): 817-825.
12. Hollander MC, Alamo I, Jackman J, Wang MG, McBride OW, Fornace AJ Jr. Analysis of the mammalian gadd45 gene and its response to DNA damage. J Biol Chem. 1993; 268(32): 24385-24393.
13. Wang K, Guo H, Hu H, et al. A functional variation in pre-microRNA-196a is associated with susceptibility of esophageal squamous cell carcinoma risk in Chinese Han. Biomarkers. 2010; 15(7): 614-618.
14. Wang K, Li J, Guo H, et al. MiR-196a binding-site SNP regulates RAP1A expression contributing to esophageal squamous cell carcinoma risk and metastasis. Carcinogenesis. 2012; 33(11): 2147-2154.
15. Wang LD, Zhou FY, Li XM, et al. Genome-wide association study of esophageal squamous cell carcinoma in Chinese subjects identifies susceptibility loci at PLCE1 and C20orf54. Nat Genet. 2010; 42(9): 759-763.
16. Wu C, Hu Z, He Z, et al. Genome-wide association study identifies three new susceptibility loci for esophageal squamous-cell carcinoma in Chinese populations. Nat Genet. 2011; 43(7): 679-684.
17. Wu C, Kraft P, Zhai K, et al. Genome-wide association analyses of esophageal squamous cell carcinoma in Chinese identify multiple susceptibility loci and geneenvironment interactions. Nat Genet. 2012; 44(10): 1090-1097.
18. Mortensen K, Skouv J, Hougaard DM, Larsson LI. Endogenous endothelial cell nitric-oxide synthase modulates apoptosis in cultured breast cancer cells and is transcriptionally regulated by p53. J Biol Chem. 1999; 274(53): 37679-37684.
19. Baker SJ, Markowitz S, Fearon ER, Willson JK, Vogelstein B. Suppression of human colorectal carcinoma cell growth by wild-type p53. Science. 1990; 249(4971): 912-915.
20. Boyle JO, Hakim J, Koch W, et al. The incidence of p53 mutations increases with progression of head and neck cancer. Cancer Res. 1993; 53(19): 4477-4480
21. Mihara M, Erster S, Zaika A, et al. p53 has a direct apoptogenic role at the mitochondria. Mol Cell. 2003; 11(3): 577-590.
22. Vousden KH, Lu X. Live or let die: the cell's response to p53. Nat Rev Cancer. 2002; 2(8): 594-604.
23. Chen K, Hu Z, Wang LE, et al. Single-nucleotide polymorphisms at the TP53-binding or responsive promoter regions of BAX and BCL2 genes and risk of squamous cell carcinoma of the head and neck. Carcinogenesis. 2007; 28(9): 2008-2012.
24. Gomes I, Collins A, Lonjou C, et al. Hardy-Weinberg quality control. Ann Hum Genet. 1999; 63(Pt 6): 535-538.
25. Hosking L, Lumsden S, Lewis K, et al. Detection of genotyping errors by Hardy-Weinberg equilibrium testing. Eur J Hum Genet. 2004; 12(5): 395-399.
26. Enjuanes A, Benavente Y, Bosch F, et al. Genetic variants in apoptosis and immunoregulation-related genes are associated with risk of chronic lymphocytic leukemia. Cancer Res. 2008; 68(24): 10178-10186.
27. Starczynski J, Pepper C, Pratt G, et al. Common polymorphism G(-248)A in the promoter region of the bax gene results in significantly shorter survival in patients with chronic lymphocytic Leukemia once treatment is initiated. J Clin Oncol. 2005; 23(7): 1514-1521.
28. Liu Z, Sun R, Lü W, et al. The-938A/A genotype of BCL2 gene is associated with esophageal cancer. Med Oncol. 2012; 29 (4): 2677-83.
29. Ma H, Chen J, Pan S, et al. Potentially functional polymorphisms in cell cycle genes and the survival of nonsmall cell lung cancer in a Chinese population. Lung Cancer. 2011; 73(1): 32-37.
30. Kim K, Sung YK, Kang CP, Choi CB, Kang C, Bae SC. A regulatory SNP at position-899 in CDKN1A is associated with systemic lupus erythematosus and lupus nephritis. Genes Immun. 2009; 10(5): 482-486.